Lifeline Total Revenue from 2010 to 2024

LLBO Stock  USD 0.0001  0.0003  75.00%   
Check Lifeline Biotechnologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lifeline Biotechnologies' main balance sheet or income statement drivers, such as , as well as many indicators such as . Lifeline financial statements analysis is a perfect complement when working with Lifeline Biotechnologies Valuation or Volatility modules.
  
This module can also supplement various Lifeline Biotechnologies Technical models . Check out the analysis of Lifeline Biotechnologies Correlation against competitors.

Pair Trading with Lifeline Biotechnologies

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Lifeline Biotechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lifeline Biotechnologies will appreciate offsetting losses from the drop in the long position's value.

Moving against Lifeline Pink Sheet

  0.57BSX Boston Scientific CorpPairCorr
  0.48EW Edwards Lifesciences CorpPairCorr
  0.47DXCM DexCom IncPairCorr
  0.45SYK StrykerPairCorr
  0.43BRK-A Berkshire HathawayPairCorr
The ability to find closely correlated positions to Lifeline Biotechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lifeline Biotechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lifeline Biotechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lifeline Biotechnologies to buy it.
The correlation of Lifeline Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Lifeline Biotechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Lifeline Biotechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Lifeline Biotechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Lifeline Pink Sheet

Lifeline Biotechnologies financial ratios help investors to determine whether Lifeline Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lifeline with respect to the benefits of owning Lifeline Biotechnologies security.